Search

cysteamine (CysAm) nanostructure was generated to act as an intermediate layer between gold electrode and carbon nanotubes. A bare gold electrode was placed in a solution of CysAm to create a self-assembled monolayer on its surface. The modified electrode was then incubated with a solution of multi-walled carbon nanotubes. Cyclic voltammetry and atomic force microscopy were used to characterize the modified electrode. The results indicated that the number of functionalized MWCNTs on the surface of the electrodes increased by enhancing incubation time. [Figure not available: see fulltext.] [ABSTRACT FROM AUTHOR]

An electrochemical immunosensor based on carbon nanofibers (CNFs) and gold nanoparticles (AuNPs) was developed for detecting anti-Toxoplasma gondii antibodies (anti-T. gondii) IgG in human serum. CNFs were produced using electrospinning and carbonization processes. Screen-printed carbon electrode (SPCE) surface was modified with CNFs and AuNPs which were electrodeposited onto the CNFs. Then, T. gondii antigen was immobilized onto the AuNPs/CNFs/SPCE. Afterward, anti-T. gondii IgG positive serum samples were coated on the modified electrode and assessed via adding anti-human IgG labeled with horseradish peroxidase (HRP) enzyme. The morphology of SPCE, CNFs, and AuNPs/CNFs/SPCE surface was characterized using field emission scanning electron microscopy (FESEM) equipped with energy dispersive spectroscopy (EDS). Characterization of CNFs was evaluated by Raman spectroscopy and X-ray diffraction (XRD). Electrochemical characterization of the immunosensor was verified using cyclic voltammetry (CV), and electrochemical response of modified electrode for anti-T. gondii IgG was detected via differential pulse voltammetry (DPV). This immunosensor was detected in the range 0–200 U mL−1 with a low detection limit (9 × 10−3 U mL−1). In addition, the proposed immunosensor was exhibited with high selectivity, strong stability, and acceptable reproducibility and repeatability. Furthermore, there was a strong correlation between results obtained via the designed immunosensor and enzyme-linked immunosorbent assay (ELISA) as gold standard. In conclusion, the developed immunosensor is a promising route for rapid and accurate clinical diagnosis of toxoplasmosis. [ABSTRACT FROM AUTHOR]